Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study.
Eur Urol Oncol. 2024 Apr 24:S2588-9311(24)00094-4. doi: 10.1016/j.euo.2024.03.013. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 38664139
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
Hitz F, Zucca E, Pabst T, Fischer N, Cairoli A, Samaras P, Caspar CB, Mach N, Krasniqi F, Schmidt A, Rothermundt C, Enoiu M, Eckhardt K, Berardi Vilei S, Rondeau S, Mey U.
Hitz F, et al. Among authors: berardi vilei s.
Br J Haematol. 2016 Jul;174(2):255-63. doi: 10.1111/bjh.14049. Epub 2016 Mar 28.
Br J Haematol. 2016.
PMID: 27018242
Free article.
Clinical Trial.
Item in Clipboard
Y90 -Ibritumomab tiuxetan (Y90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05).
Voegeli M, Rondeau S, Berardi Vilei S, Lerch E, Wannesson L, Pabst T, Rentschler J, Bargetzi M, Jost L, Ketterer N, Bischof Delaloye A, Ghielmini M.
Voegeli M, et al. Among authors: berardi vilei s.
Hematol Oncol. 2017 Dec;35(4):576-583. doi: 10.1002/hon.2348. Epub 2016 Sep 28.
Hematol Oncol. 2017.
PMID: 27677906
Clinical Trial.
Item in Clipboard
Complete subchondral bone defect regeneration with a tricalcium phosphate collagen implant and osteoinductive growth factors: a randomized controlled study in Göttingen minipigs.
Gotterbarm T, Breusch SJ, Jung M, Streich N, Wiltfang J, Berardi Vilei S, Richter W, Nitsche T.
Gotterbarm T, et al. Among authors: berardi vilei s.
J Biomed Mater Res B Appl Biomater. 2014 Jul;102(5):933-42. doi: 10.1002/jbm.b.33074. Epub 2013 Nov 21.
J Biomed Mater Res B Appl Biomater. 2014.
PMID: 24259283
Item in Clipboard
Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial.
Hitz F, Fischer N, Pabst T, Caspar C, Berthod G, Eckhardt K, Berardi Vilei S, Zucca E, Mey U; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
Hitz F, et al. Among authors: berardi vilei s.
Ann Hematol. 2013 Aug;92(8):1033-40. doi: 10.1007/s00277-013-1751-z. Epub 2013 Apr 17.
Ann Hematol. 2013.
PMID: 23592273
Free article.
Clinical Trial.
Item in Clipboard
An in vivo study of a growth-factor enhanced, cell free, two-layered collagen-tricalcium phosphate in deep osteochondral defects.
Gotterbarm T, Richter W, Jung M, Berardi Vilei S, Mainil-Varlet P, Yamashita T, Breusch SJ.
Gotterbarm T, et al. Among authors: berardi vilei s.
Biomaterials. 2006 Jun;27(18):3387-95. doi: 10.1016/j.biomaterials.2006.01.041. Epub 2006 Feb 20.
Biomaterials. 2006.
PMID: 16488472
Item in Clipboard
Cite
Cite